gavrilovaefivu.blogspot.com
The money was granted in collaborationn withthe U.S. Army Medicalp Research and Materiel Command and the throughthe Ft. Detricj Technology Transfer Initiative. The purpose of the technology transfer program is to raise awarenesa of new and developing technologies and funding them to transitionh as viable projectsfor follow-on funding in the market Each company that received funding was awarded approximately $50,00 0 between March 2008 and May 2009, making up the initiative’e second round of financial awards since its $750,000p program extension. The fundxs for the program’s second phase were secure by Sen. Barbara Mikulski, D-Md., and Rep. Roscoe G. R-Md. “The [Ft.
Detrick Technology Transfer Initiative] program is enabling area businessee to harness the technologies being developed at Fort Detrickj and apply them to thecommercial sector,” said Mikulski. “Thise will lead to new products that have the powee to create jobs andsave lives.” Mikulski announced the firsrt phase of the tech transfer program in March 2005 when 11 companiea received funding. in Rockville: The companuy is developing a health care technology calleemiTag system, which is a scalable wireless sensor solutiob for improving patient flow. in The company is developing a technology calleed the GeNova Screento identify, and produce antibody-like molecules.
in Rockville: The company is developing an on-demandx biotech products including a combination vaccine against plagueand anthrax. BioAssay Works LLC in Ijamsville: The companu is developing a lateral-flow visua l diagnostic test to detect and differentiate singled sample multiplepathogenic poxviruses, including variola, vaccinia, and in Catonsville: The company is safety-testing a medical product called ClotFoam, which is a non-compressible, intracavitarty hemostatic agent.
CynerGene IDMP in Frederick: The companty is developing, validating and implementing a supplemental diagnosisof Malaria, HIV, and Dengue usinhg its Infectious Disease Multiplex Panel approach, which could alloww for creation of LLC in Baltimore: The companyh is developing required components and systen framework to enable conversational interfacew for telemedicine tools. Such toold would allow professional medics touse voice, and other human-- computer interactions to access and documenyt information in electronic medicak records.
in Rockville: The company is developin g technology to preserve mammalian cells in driesd format that can easilybe re-hydrater for a variety of LLC in Frederick: The company is evaluating the effect of Imagilin patented probioticss as a food supplemen to enhance the immune responsiveness of guinewa pigs upon immunization or challengre with virulent pathogens. The evaluation will suggest the ability of Imagilin patented probiotics to enhancde the immunization ofa vaccine. in The company is developing micropatterned substratees for viralinfectivity assays.
Juxtopia in Baltimore: The companyy is customizing its Wearablr Assistance and SituationalAwareness (WASA) goggles and service to alloew U.S. Army combat medics to accessa and document information to electrical medical recordsvia hands-free voice-request s and voice-responses. in Baltimore: The company is developing cell therapiews to treat brain and spinalcord
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment